1st Quarter - Report
LYMPHOMA RESEARCH FOUNDATION for LYMPHOMA RESEARCH FOUNDATION
Client
Income
—
Expenses
$6,199
Expense method
A: Lobbying Disclosure Act definitions
What was lobbied
One issue area, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Cancer Drug Parity Act of 2015 (H.R. 2739/ S. 1566) Department of Defense Peer Reviewed Cancer Research Program
| Lobbyist | Covered position, as disclosed |
|---|---|
| ROBIN R LEVY | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.